Found: 10
Select item for more details and to access through your institution.
Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 2, p. 221, doi. 10.1093/cid/cit226
- By:
- Publication type:
- Article
LB6. EDP-938, a Novel RSV N-Inhibitor, Administered Once or Twice Daily Was Safe and Demonstrated Robust Antiviral and Clinical Efficacy in a Healthy Volunteer Challenge Study.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S995, doi. 10.1093/ofid/ofz415.2489
- By:
- Publication type:
- Article
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B.
- Published in:
- Antiviral Therapy, 2022, v. 27, n. 6, p. 1, doi. 10.1177/13596535221127848
- By:
- Publication type:
- Article
Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034372
- By:
- Publication type:
- Article
The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 2, p. 431, doi. 10.1111/j.1365-2125.2012.04345.x
- By:
- Publication type:
- Article
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV.
- Published in:
- Annals of Internal Medicine, 2013, v. 159, n. 2, p. 86
- By:
- Publication type:
- Article
EDP‐297: A novel, farnesoid X receptor agonist—Results of a phase I study in healthy subjects.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 2, p. 338, doi. 10.1111/cts.13453
- By:
- Publication type:
- Article
The Pharmacokinetic Interaction Between an Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone and the HCV Protease Inhibitor Telaprevir.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 10, p. 1574, doi. 10.1177/0091270011419855
- By:
- Publication type:
- Article
Assessment of drug–drug interaction potential with EDP‐305, a farnesoid X receptor agonist, in healthy subjects.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 9, p. 2146, doi. 10.1111/cts.13348
- By:
- Publication type:
- Article